Neutralizing antibodies – Page 134 – Communicable Diseases Research

COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis

Review

Published on 2020-07-212022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19, SARS,

[키워드] ACE2 addition Affect angiotensin Anti-inflammatory drugs antibody attenuate binding CD4+ T cell CD8+ clinical trial common cold contribute coronavirus 2 correlated country CoV COVID-19 infection develop diffusion drug Efficacy enzymatic activity Frequency functional healthcare identify immune immune system immunization in viral infect Infection involved measure Neutralizing antibodies outbreak outcome pandemic Patient Perspective Pneumonia positive prevention receptor Replication resources respiratory review SARS-CoV2 SARS-CoV2 infection severe respiratory syndrome severity single-stranded RNA virus Symptom the disease Tocilizumab Transcription Treatment turn Vaccine virus
[DOI] 10.3390/ijms21145145 PMC 바로가기 [Article Type] Review

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes

Article

Published on 2020-07-152022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] acute respiratory syndrome analyzed antibodies antiviral therapy approved biosafety Biosafety Level 3 can be used caused classical coefficient convalescent COVID-19 patient convalescent COVID-19 patients coronavirus correlated detect determine displaying genus Betacoronavirus homologous Immune status morbidities MOST neutralization titer neutralized Neutralizing antibodies neutralizing antibody Neutralizing antibody titer pandemic virus passive immunization patient cohort Pearson correlation performed pseudotype virus pseudovirus quantification Rapid robust SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 neutralization SARS-CoV-2-neutralizing antibodies SARS-CoV-2-neutralizing antibody sera serum Spike protein the SARS-CoV-2 therapeutic vaccinated individuals Vaccine Vaccines vesicular vesicular stomatitis virus VSV
[DOI] 10.3390/vaccines8030386 PMC 바로가기 [Article Type] Article

In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies

Review

Published on 2020-07-052023-06-15
Journal: Emerging Microbes & Infections [Category] MERS,

[키워드] antibody cocktail antivirals DNA therapeutics Electroporation Emerging infectious disease gene transfer Neutralizing antibodies
[DOI] 10.1080/22221751.2020.1787108 PMC 바로가기 [Article Type] Review

Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies

Original Article

Published on 2020-07-042023-06-15
Journal: Cellular and Molecular Life Sciences [Category] MERS, SARS,

[키워드] ACE2 and ACE inhibitors Comparative modeling coronavirus COVID-19 Fold recognition tools n-CoV19 Neutralizing antibodies Receptor binding domain SARS-CoV-2 spike Spike post-fusion conformation
[DOI] 10.1007/s00018-020-03580-1 PMC 바로가기 [Article Type] Original Article

Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection

Article

Published on 2020-07-032023-07-02
Journal: Cell Reports [Category] SARS,

[키워드] coronavirus COVID-19 cross-neutralizing antibody epitope human antibodies Infection Neutralizing antibodies RBD SARS-CoV-2 Spike protein
[DOI] 10.1016/j.celrep.2020.107918 PMC 바로가기 [Article Type] Article

Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases

Research article

Published on 2020-07-012022-10-05
Journal: Diabetes & metabolic syndrome [Category] SARS, 치료법,

SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets

Article

Published on 2020-06-272023-06-14
Journal: Biochimica et biophysica acta. Molecular basis of [Category] MERS, SARS,

[키워드] ACE2, angiotensin-converting enzyme 2 AT2 Cells, alveolar epithelial type2 cells ATG, autophagy-related genes BBB, blood-brain barrier Brain CNS, Center nervous System COPD, Chronic obstructive pulmonary disease COVID-19 COVID-19, Coronavirus Disease discovered in 2019 Diabetes Mellitus DM, diabetes mellitus DMV, double-membrane vesicles EM, electron microscope HAPE, High altitude pulmonary edema HCQ, hydroxychloroquine IFN, Interferons IL, interleukin MERS-CoV, Middle East respiratory syndrome coronavirus MHV, mouse hepatitis virus MMPs, matrix metalloproteinases MS, multiple sclerosis multiple sclerosis NAb's, Neutralizing antibodies Neutralizing antibodies NSP, non-structural protein ORF, open reading frame SARS-CoV-2 SARS-CoV, severe acute respiratory syndrome coronavirus ssRNA, single-strand RNA Therapeutics TNF, Tumor Necrosis Factor ULK, ubiquitin-like ligase
[DOI] 10.1016/j.bbadis.2020.165889 PMC 바로가기 [Article Type] Article

COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds

Minireview

Published on 2020-06-262022-10-30
Journal: Journal of Virology [Category] COVID-19, MERS,

Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively

Immunoassays

Published on 2020-06-242022-10-30
Journal: Journal of Clinical Microbiology [Category] COVID-19, MERS,

[키워드] acute respiratory syndrome antibody automated average chemiluminescence CLIA clinical coronavirus CoV COVID-19 COVID-19 diagnosis Cutoff Diagnosis diagnostic diagnostics disease evaluated IgG immunoassays immunoserology Laboratory LIAISON measure Neutralization assay Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody neutralizing capacity offered pandemic performance plasma positive Predictive Protein provided ranged S1/S2 Safe SARS-CoV-2 selective sensitivity Serological testing serum specificity spike Test the SARS-CoV-2 therapeutic use to define Variation
[DOI] 10.1128/JCM.01224-20 PMC 바로가기 [Article Type] Immunoassays

SARS-CoV-2 neutralizing antibody development strategies

Article

Published on 2020-06-212022-10-29
Journal: Turkish Journal of Biology [Category] COVID-19,